APO Research
Talk to an analyst

APO RESEARCH · REPORT

MRI Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global MRI Contrast Agents Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchMRI Contrast Agents Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal MRI Contrast Agents Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal MRI Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal MRI Contrast Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal MRI Contrast Agents Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global MRI Contrast Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for MRI Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for MRI Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for MRI Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the MRI Contrast Agents market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the MRI Contrast Agents market include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma and Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global MRI Contrast Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of MRI Contrast Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents MRI Contrast Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the MRI Contrast Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

MRI Contrast Agents Segment by Company

Bayer

Guerbet Group

Bracco Imaging

GE Healthcare

BeiLu Pharma

Hengrui Medicine

MRI Contrast Agents Segment by Type

Gadobutrol

Gadoterate Meglumine

Gadobenate Dimeglumine

Gadopentetate Dimeglumine

Gadoteridol

Gadodiamine

Others

MRI Contrast Agents Segment by Application

Hospitals

Clinics

MRI Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global MRI Contrast Agents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions MRI Contrast Agents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify MRI Contrast Agents significant trends, drivers, influence factors in global and regions.

6. To analyze MRI Contrast Agents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MRI Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of MRI Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MRI Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the MRI Contrast Agents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global MRI Contrast Agents industry.

Chapter 3: Detailed analysis of MRI Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of MRI Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of MRI Contrast Agents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. MRI Contrast Agents Industry Trends Table 2. MRI Contrast Agents Industry Drivers Table 3. MRI Contrast Agents Industry Opportunities and Challenges Table 4. MRI Contrast Agents Industry Restraints Table 5. Global MRI Contrast Agents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global MRI Contrast Agents Revenue Share by Company (2021-2026) Table 7. Global MRI Contrast Agents Sales Volume by Company (Liter) & (2021-2026) Table 8. Global MRI Contrast Agents Sales Volume Share by Company (2021-2026) Table 9. Global MRI Contrast Agents Average Price (US$/mL) of Company (2021-2026) Table 10. Global MRI Contrast Agents Company Ranking, (2024-2026) & (USD Million) Table 11. Global MRI Contrast Agents Key Company Manufacturing Base & Headquarters Table 12. Global MRI Contrast Agents Company, Product Type & Application Table 13. Global MRI Contrast Agents Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global MRI Contrast Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Gadobutrol Table 18. Significant Companies of Gadoterate Meglumine Table 19. Significant Companies of Gadobenate Dimeglumine Table 20. Significant Companies of Gadopentetate Dimeglumine Table 21. Significant Companies of Gadoteridol Table 22. Significant Companies of Gadodiamine Table 23. Significant Companies of Others Table 24. Global MRI Contrast Agents Sales Volume by Type 2021 VS 2025 VS 2032 (Liter) Table 25. Global MRI Contrast Agents Sales Volume by Type (2021-2026) & (Liter) Table 26. Global MRI Contrast Agents Sales Volume by Type (2027-2032) & (Liter) Table 27. Global MRI Contrast Agents Sales Volume Share by Type (2021-2026) Table 28. Global MRI Contrast Agents Sales Volume Share by Type (2027-2032) Table 29. Global MRI Contrast Agents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global MRI Contrast Agents Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global MRI Contrast Agents Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global MRI Contrast Agents Sales Value Share by Type (2021-2026) Table 33. Global MRI Contrast Agents Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Hospitals Table 35. Significant Companies of Clinics Table 36. Global MRI Contrast Agents Sales Volume by Application 2021 VS 2025 VS 2032 (Liter) Table 37. Global MRI Contrast Agents Sales Volume by Application (2021-2026) & (Liter) Table 38. Global MRI Contrast Agents Sales Volume by Application (2027-2032) & (Liter) Table 39. Global MRI Contrast Agents Sales Volume Share by Application (2021-2026) Table 40. Global MRI Contrast Agents Sales Volume Share by Application (2027-2032) Table 41. Global MRI Contrast Agents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global MRI Contrast Agents Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global MRI Contrast Agents Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global MRI Contrast Agents Sales Value Share by Application (2021-2026) Table 45. Global MRI Contrast Agents Sales Value Share by Application (2027-2032) Table 46. Global MRI Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (Liter) Table 47. Global MRI Contrast Agents Sales by Region (2021-2026) & (Liter) Table 48. Global MRI Contrast Agents Sales Market Share by Region (2021-2026) Table 49. Global MRI Contrast Agents Sales by Region (2027-2032) & (Liter) Table 50. Global MRI Contrast Agents Sales Market Share by Region (2027-2032) Table 51. Global MRI Contrast Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global MRI Contrast Agents Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global MRI Contrast Agents Sales Value Share by Region (2021-2026) Table 54. Global MRI Contrast Agents Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global MRI Contrast Agents Sales Value Share by Region (2027-2032) Table 56. Global MRI Contrast Agents Market Average Price (US$/mL) by Region (2021-2026) Table 57. Global MRI Contrast Agents Market Average Price (US$/mL) by Region (2027-2032) Table 58. Global MRI Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (Liter) Table 59. Global MRI Contrast Agents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global MRI Contrast Agents Sales by Country (2021-2026) & (Liter) Table 61. Global MRI Contrast Agents Sales Market Share by Country (2021-2026) Table 62. Global MRI Contrast Agents Sales by Country (2027-2032) & (Liter) Table 63. Global MRI Contrast Agents Sales Market Share by Country (2027-2032) Table 64. Global MRI Contrast Agents Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global MRI Contrast Agents Sales Value Market Share by Country (2021-2026) Table 66. Global MRI Contrast Agents Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global MRI Contrast Agents Sales Value Market Share by Country (2027-2032) Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer MRI Contrast Agents Sales (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 71. Bayer MRI Contrast Agents Product Portfolio Table 72. Bayer Recent Development Table 73. Guerbet Group Company Information Table 74. Guerbet Group Business Overview Table 75. Guerbet Group MRI Contrast Agents Sales (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 76. Guerbet Group MRI Contrast Agents Product Portfolio Table 77. Guerbet Group Recent Development Table 78. Bracco Imaging Company Information Table 79. Bracco Imaging Business Overview Table 80. Bracco Imaging MRI Contrast Agents Sales (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 81. Bracco Imaging MRI Contrast Agents Product Portfolio Table 82. Bracco Imaging Recent Development Table 83. GE Healthcare Company Information Table 84. GE Healthcare Business Overview Table 85. GE Healthcare MRI Contrast Agents Sales (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 86. GE Healthcare MRI Contrast Agents Product Portfolio Table 87. GE Healthcare Recent Development Table 88. BeiLu Pharma Company Information Table 89. BeiLu Pharma Business Overview Table 90. BeiLu Pharma MRI Contrast Agents Sales (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 91. BeiLu Pharma MRI Contrast Agents Product Portfolio Table 92. BeiLu Pharma Recent Development Table 93. Hengrui Medicine Company Information Table 94. Hengrui Medicine Business Overview Table 95. Hengrui Medicine MRI Contrast Agents Sales (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 96. Hengrui Medicine MRI Contrast Agents Product Portfolio Table 97. Hengrui Medicine Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. MRI Contrast Agents Distributors List Table 101. MRI Contrast Agents Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. MRI Contrast Agents Product Image Figure 2. Global MRI Contrast Agents Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global MRI Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 4. Global MRI Contrast Agents Sales (2021-2032) & (Liter) Figure 5. Global MRI Contrast Agents Sales Average Price (US$/mL) & (2021-2032) Figure 6. Global MRI Contrast Agents Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gadobutrol Image Figure 10. Gadoterate Meglumine Image Figure 11. Gadobenate Dimeglumine Image Figure 12. Gadopentetate Dimeglumine Image Figure 13. Gadoteridol Image Figure 14. Gadodiamine Image Figure 15. Others Image Figure 16. Global MRI Contrast Agents Sales Volume by Type (2021 VS 2025 VS 2032) & (Liter) Figure 17. Global MRI Contrast Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global MRI Contrast Agents Sales Volume Share by Type (2021-2032) Figure 19. Global MRI Contrast Agents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global MRI Contrast Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global MRI Contrast Agents Sales Value Share by Type (2021-2032) Figure 22. Hospitals Image Figure 23. Clinics Image Figure 24. Global MRI Contrast Agents Sales Volume by Application (2021 VS 2025 VS 2032) & (Liter) Figure 25. Global MRI Contrast Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global MRI Contrast Agents Sales Volume Share by Application (2021-2032) Figure 27. Global MRI Contrast Agents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global MRI Contrast Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global MRI Contrast Agents Sales Value Share by Application (2021-2032) Figure 30. Global MRI Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (Liter) Figure 31. Global MRI Contrast Agents Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global MRI Contrast Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global MRI Contrast Agents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America MRI Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 35. North America MRI Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe MRI Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 37. Europe MRI Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific MRI Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific MRI Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America MRI Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 41. South America MRI Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa MRI Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa MRI Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt MRI Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. MRI Contrast Agents Value Chain Figure 129. Manufacturing Cost Structure Figure 130. MRI Contrast Agents Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Gadobutrol
  • Gadoterate Meglumine
  • Gadobenate Dimeglumine
  • Gadopentetate Dimeglumine
  • Gadoteridol
  • Gadodiamine
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Bayer
  • Guerbet Group
  • Bracco Imaging
  • GE Healthcare
  • BeiLu Pharma
  • Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global MRI Contrast Agents Sales Value (2021-2032)
  4. 1.2.2 Global MRI Contrast Agents Sales Volume (2021-2032)
  5. 1.2.3 Global MRI Contrast Agents Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 MRI Contrast Agents Market Dynamics
  1. 2.1 MRI Contrast Agents Industry Trends
  2. 2.2 MRI Contrast Agents Industry Drivers
  3. 2.3 MRI Contrast Agents Industry Opportunities and Challenges
  4. 2.4 MRI Contrast Agents Industry Restraints
3 MRI Contrast Agents Market by Company
  1. 3.1 Global MRI Contrast Agents Company Revenue Ranking in 2025
  2. 3.2 Global MRI Contrast Agents Revenue by Company (2021-2026)
  3. 3.3 Global MRI Contrast Agents Sales Volume by Company (2021-2026)
  4. 3.4 Global MRI Contrast Agents Average Price by Company (2021-2026)
  5. 3.5 Global MRI Contrast Agents Company Ranking (2024-2026)
  6. 3.6 Global MRI Contrast Agents Company Manufacturing Base and Headquarters
  7. 3.7 Global MRI Contrast Agents Company Product Type and Application
  8. 3.8 Global MRI Contrast Agents Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global MRI Contrast Agents Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 MRI Contrast Agents Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 MRI Contrast Agents Market by Type
  1. 4.1 MRI Contrast Agents Type Introduction
  2. 4.1.1 Gadobutrol
  3. 4.1.2 Gadoterate Meglumine
  4. 4.1.3 Gadobenate Dimeglumine
  5. 4.1.4 Gadopentetate Dimeglumine
  6. 4.1.5 Gadoteridol
  7. 4.1.6 Gadodiamine
  8. 4.1.7 Others
  9. 4.2 Global MRI Contrast Agents Sales Volume by Type
  10. 4.2.1 Global MRI Contrast Agents Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global MRI Contrast Agents Sales Volume by Type (2021-2032)
  12. 4.2.3 Global MRI Contrast Agents Sales Volume Share by Type (2021-2032)
  13. 4.3 Global MRI Contrast Agents Sales Value by Type
  14. 4.3.1 Global MRI Contrast Agents Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global MRI Contrast Agents Sales Value by Type (2021-2032)
  16. 4.3.3 Global MRI Contrast Agents Sales Value Share by Type (2021-2032)
5 MRI Contrast Agents Market by Application
  1. 5.1 MRI Contrast Agents Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global MRI Contrast Agents Sales Volume by Application
  5. 5.2.1 Global MRI Contrast Agents Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global MRI Contrast Agents Sales Volume by Application (2021-2032)
  7. 5.2.3 Global MRI Contrast Agents Sales Volume Share by Application (2021-2032)
  8. 5.3 Global MRI Contrast Agents Sales Value by Application
  9. 5.3.1 Global MRI Contrast Agents Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global MRI Contrast Agents Sales Value by Application (2021-2032)
  11. 5.3.3 Global MRI Contrast Agents Sales Value Share by Application (2021-2032)
6 MRI Contrast Agents Regional Sales and Value Analysis
  1. 6.1 Global MRI Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global MRI Contrast Agents Sales by Region (2021-2032)
  3. 6.2.1 Global MRI Contrast Agents Sales by Region: 2021-2026
  4. 6.2.2 Global MRI Contrast Agents Sales by Region (2027-2032)
  5. 6.3 Global MRI Contrast Agents Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global MRI Contrast Agents Sales Value by Region (2021-2032)
  7. 6.4.1 Global MRI Contrast Agents Sales Value by Region: 2021-2026
  8. 6.4.2 Global MRI Contrast Agents Sales Value by Region (2027-2032)
  9. 6.5 Global MRI Contrast Agents Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America MRI Contrast Agents Sales Value (2021-2032)
  12. 6.6.2 North America MRI Contrast Agents Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe MRI Contrast Agents Sales Value (2021-2032)
  15. 6.7.2 Europe MRI Contrast Agents Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific MRI Contrast Agents Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific MRI Contrast Agents Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America MRI Contrast Agents Sales Value (2021-2032)
  21. 6.9.2 South America MRI Contrast Agents Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa MRI Contrast Agents Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa MRI Contrast Agents Sales Value Share by Country, 2025 VS 2032
7 MRI Contrast Agents Country-level Sales and Value Analysis
  1. 7.1 Global MRI Contrast Agents Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global MRI Contrast Agents Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global MRI Contrast Agents Sales by Country (2021-2032)
  4. 7.3.1 Global MRI Contrast Agents Sales by Country (2021-2026)
  5. 7.3.2 Global MRI Contrast Agents Sales by Country (2027-2032)
  6. 7.4 Global MRI Contrast Agents Sales Value by Country (2021-2032)
  7. 7.4.1 Global MRI Contrast Agents Sales Value by Country (2021-2026)
  8. 7.4.2 Global MRI Contrast Agents Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt MRI Contrast Agents Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt MRI Contrast Agents Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt MRI Contrast Agents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer MRI Contrast Agents Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bayer MRI Contrast Agents Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Guerbet Group
  8. 8.2.1 Guerbet Group Company Information
  9. 8.2.2 Guerbet Group Business Overview
  10. 8.2.3 Guerbet Group MRI Contrast Agents Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Guerbet Group MRI Contrast Agents Product Portfolio
  12. 8.2.5 Guerbet Group Recent Developments
  13. 8.3 Bracco Imaging
  14. 8.3.1 Bracco Imaging Company Information
  15. 8.3.2 Bracco Imaging Business Overview
  16. 8.3.3 Bracco Imaging MRI Contrast Agents Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bracco Imaging MRI Contrast Agents Product Portfolio
  18. 8.3.5 Bracco Imaging Recent Developments
  19. 8.4 GE Healthcare
  20. 8.4.1 GE Healthcare Company Information
  21. 8.4.2 GE Healthcare Business Overview
  22. 8.4.3 GE Healthcare MRI Contrast Agents Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GE Healthcare MRI Contrast Agents Product Portfolio
  24. 8.4.5 GE Healthcare Recent Developments
  25. 8.5 BeiLu Pharma
  26. 8.5.1 BeiLu Pharma Company Information
  27. 8.5.2 BeiLu Pharma Business Overview
  28. 8.5.3 BeiLu Pharma MRI Contrast Agents Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BeiLu Pharma MRI Contrast Agents Product Portfolio
  30. 8.5.5 BeiLu Pharma Recent Developments
  31. 8.6 Hengrui Medicine
  32. 8.6.1 Hengrui Medicine Company Information
  33. 8.6.2 Hengrui Medicine Business Overview
  34. 8.6.3 Hengrui Medicine MRI Contrast Agents Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hengrui Medicine MRI Contrast Agents Product Portfolio
  36. 8.6.5 Hengrui Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 MRI Contrast Agents Value Chain Analysis
  2. 9.1.1 MRI Contrast Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 MRI Contrast Agents Sales Mode & Process
  6. 9.2 MRI Contrast Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 MRI Contrast Agents Distributors
  9. 9.2.3 MRI Contrast Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst